Although both SP100 and TGFB3 displayed differential positioning patterns between low and intermediate/high Gleason score cancer specimens, the sensitivity for subgrouping prostate cancers by Gleason score based on positioning patterns is low. This evidence concerns the gene TGFB3 and prostate carcinoma.